Skip to main navigation Skip to search Skip to main content

The cost of Alzheimer's disease in China and re-estimation of costs worldwide

  • Jianping Jia
  • , Cuibai Wei
  • , Shuoqi Chen
  • , Fangyu Li
  • , Yi Tang
  • , Wei Qin
  • , Lina Zhao
  • , Hongmei Jin
  • , Hui Xu
  • , Fen Wang
  • , Aihong Zhou
  • , Xiumei Zuo
  • , Liyong Wu
  • , Ying Han
  • , Yue Han
  • , Liyuan Huang
  • , Qi Wang
  • , Dan Li
  • , Changbiao Chu
  • , Lu Shi
  • Min Gong, Yifeng Du, Jiewen Zhang, Junjian Zhang, Chunkui Zhou, Jihui Lv, Yang Lv, Haiqun Xie, Yong Ji, Fang Li, Enyan Yu, Benyan Luo, Yanjiang Wang, Shanshan Yang, Qiumin Qu, Qihao Guo, Furu Liang, Jintao Zhang, Lan Tan, Lu Shen, Kunnan Zhang, Jinbiao Zhang, Dantao Peng, Muni Tang, Peiyuan Lv, Boyan Fang, Lan Chu, Longfei Jia, Serge Gauthier
  • Capital Medical University
  • Beijing Key Laboratory of Geriatric Cognitive Disorders
  • Key Lab of the Ministry of Education for Process Control and Efficiency Egineering
  • National Clinical Research Center for Geriatric Disorders
  • Shandong University
  • Henan Provincial People's Hospital
  • Zhongnan Hospital of Wuhan University
  • Jilin University
  • Beijing Geriatric Hospital
  • First Affiliated Hospital of Chongqing Medical University
  • Sun Yat-Sen University
  • Tianjin Huanhu Hospital
  • Zhejiang Provincial People's Hospital
  • Zhejiang University School of Medicine
  • Daping Hospital, the Third Military Medical University
  • Daqing Oilfield Company Ltd.
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • Huashan Hospital
  • Baotou City Central Hospital
  • The 88th Hospital of PLA
  • Qingdao University
  • Central South University
  • People's Hospital of Jiangxi Province
  • Weihai Municipal Hospital
  • China-Japan Friendship Hospital
  • Medical University (Guangzhou Huiai Hospital)
  • Hebei General Hospital
  • Guizhou Medical University
  • Henry Ford Health System
  • McGill University

Research output: Contribution to journalArticlepeer-review

717 Scopus citations

Abstract

Introduction: The socioeconomic costs of Alzheimer's disease (AD) in China and its impact on global economic burden remain uncertain. Methods: We collected data from 3098 patients with AD in 81 representative centers across China and estimated AD costs for individual patient and total patients in China in 2015. Based on this data, we re-estimated the worldwide costs of AD. Results: The annual socioeconomic cost per patient was US $19,144.36, and total costs were US $167.74 billion in 2015. The annual total costs are predicted to reach US $507.49 billion in 2030 and US $1.89 trillion in 2050. Based on our results, the global estimates of costs for dementia were US $957.56 billion in 2015, and will be US $2.54 trillion in 2030, and US $9.12 trillion in 2050, much more than the predictions by the World Alzheimer Report 2015. Discussion: China bears a heavy burden of AD costs, which greatly change the estimates of AD cost worldwide.

Original languageEnglish
Pages (from-to)483-491
Number of pages9
JournalAlzheimer's and Dementia
Volume14
Issue number4
DOIs
StatePublished - Apr 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Alzheimer's
  • Cost of illness
  • Dementia
  • Observational study

Fingerprint

Dive into the research topics of 'The cost of Alzheimer's disease in China and re-estimation of costs worldwide'. Together they form a unique fingerprint.

Cite this